We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
5601
Lexicon Pharmaceuticals
LXRX
$1.1B
$201K ﹤0.01%
48,448
+24,370
+101% +$93.8K
FSTA icon
5602
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$200K ﹤0.01%
5,304
+1,663
+46% +$61.2K
TWM icon
5603
ProShares UltraShort Russell2000
TWM
$41.3M
$200K ﹤0.01%
+796
New +$222K
PZN
5604
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$200K ﹤0.01%
23,181
+8,153
+54% +$70.2K
PLSE icon
5605
Pulse Biosciences
PLSE
$3.02B
$199K ﹤0.01%
14,874
+1,583
+12% +$22.6K
SVRA icon
5606
Savara
SVRA
$1.19B
$199K ﹤0.01%
44,391
+13,464
+44% +$16.2K
ULH icon
5607
Universal Logistics Holdings
ULH
$529M
$199K ﹤0.01%
10,474
+2,760
+36% +$57.6K
HARP
5608
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$199K ﹤0.01%
1,346
+777
+137% +$118K
AMRS
5609
DELISTED
Amyris Inc.
AMRS
$199K ﹤0.01%
64,421
+49,699
+338% +$184K
FNI
5610
DELISTED
First Trust Chindia ETF
FNI
$197K ﹤0.01%
4,960
-255
-5% -$9.45K
BPY
5611
CALL
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$197K ﹤0.01%
10,800
HWBK icon
5612
Hawthorn Bancshares
HWBK
$278M
$196K ﹤0.01%
8,989
+3,108
+53% +$64.4K
ANIK icon
5613
Anika Therapeutics
ANIK
$287M
$195K ﹤0.01%
3,760
-33,524
-90% -$1.95M
REV
5614
DELISTED
Revlon, Inc.
REV
$195K ﹤0.01%
9,128
+2,267
+33% +$54.6K
FNCL icon
5615
Fidelity MSCI Financials Index ETF
FNCL
$2.4B
$194K ﹤0.01%
4,359
-32,087
-88% -$1.36M
NGS icon
5616
Natural Gas Services Group
NGS
$477M
$194K ﹤0.01%
15,838
+6,295
+66% +$74.2K
NUM
5617
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
$194K ﹤0.01%
13,703
-1,240
-8% -$17.4K
WEBK
5618
DELISTED
Wellesley Bancorp, Inc.
WEBK
$194K ﹤0.01%
4,278
+1,278
+43% +$45.9K
EMSH
5619
DELISTED
ProShares Short Term USD Emerging Markets Bond ETF
EMSH
$194K ﹤0.01%
2,577
-435
-14% -$32.6K
EDC icon
5620
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$161M
$193K ﹤0.01%
2,156
+1,722
+397% +$130K
HBB icon
5621
Hamilton Beach Brands
HBB
$422M
$193K ﹤0.01%
10,097
+2,640
+35% +$48.5K
WHLR
5622
Wheeler Real Estate Investment Trust
WHLR
$412K
0
ADN
5623
DELISTED
Advent Technologies
ADN
$192K ﹤0.01%
+633
New +$191K
BWZ icon
5624
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$289M
$192K ﹤0.01%
6,202
+1,406
+29% +$42.9K
DBVT
5625
DBV Technologies
DBVT
$847M
$192K ﹤0.01%
1,796
-1,200
-40% -$96K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.